Pieces of Missing DNA Could Hold Key to Prevent Breast Cancer

Researches have shown that women who develop beast cancer at a young age have certain pieces of their DNA missing.

Breast cancer can occur in women and rarely in men. Breast cancer starts when cells in the breast begin to grow out of control and affects 1 in 8 women during their lives.

Women who develop the condition at a young age have certain pieces of their DNA missing, this revelation could help find ways to prevent breast cancer.

RNA Molecule Identified to Shield Breast Cancer Stem Cells
A small RNA molecule has been recently identified to shield breast cancer stem cells.

‘Treatment for breast cancer depends on the stage of cancer. It may consist of chemotherapy, radiation, hormone therapy and surgery.’

The discovery could hold the key to helping young women beat the disease, according to the researchers who studied the DNA of hundreds of Australian women aged under 40 who had developed breast cancer.

"We were trying to find genetic causes for why these women developed the disease at such an early age," said Logan Walker from University of Otago, Christchurch, New Zealand.

The women "missed" certain bits of their DNA, showed the findings published in the journal Breast Cancer Research.

Computer Accurately Describes Breast Cancers on Digital Tissue Slides
Deep-learning computer network could help to automate biopsy slides for breast cancer, reveals study.

"We think these pieces of DNA that are missing may have overlapped genes or involved genes that have contributed to the early onset of breast cancer," Walker said, adding that he hopes the finding could one day identify women at risk of developing cancer at a young age, and improve treatment and survival rates.

"If we can identify the genes that underlie risk, or the sorts of things that cause disease in these young women, then we can potentially identify those women before the disease has occurred, and if we can do that we can minimise the risk of or prevent the disease from occurring in the first place," Walker said.

Breast Cancer Drug �Tamoxifen� Protects Against Obesity-Related Metabolic Disorders
Tamoxifen drug used in the treatment of breast cancer could prevent obesity, fatty liver and insulin resistance, finds study.

The study was conducted in collaborative with scientists from the University of Melbourne in Australia.

"Genetic testing typically shows that 10 per cent of young women who develop breast cancer have inherited a mutation in known breast cancer susceptibility genes - the most widely publicised being BRCA1 and BRCA2," Walker pointed out.

Post-traumatic Stress Could Affect Cognitive Function in Breast Cancer Patients
Post-traumatic stress could often be associated with cognitive dysfunction and decline in breast cancer patients, reveals study.

"This leaves the majority of the young women with no explanation. We are trying to change this through our work in collaboration with large international studies using cutting-edge DNA analysis tools," he said.

To confirm the findings of his study, the DNA of tens of thousands of women from around the world should be checked, Walker said.

Source-IANS